STRATEGIC ADVISOR & INVESTOR — RxGPT (Healthcare AI)

Company Description

RxGPT, a leading AI-driven healthcare venture under Get

Hired Global, revolutionizes hospital operations by automating patient routing, administrative tasks, and communication. By enabling healthcare teams to focus on delivering quality care, RxGPT enhances operational efficiency and patient-centricity. Known for its fast onboarding, seamless integration, and robust security, RxGPT offers innovative solutions tailored to the healthcare industry. Founded by Sailesh Pattnaik, a strategic leader with over 17 years of enterprise experience, RxGPT combines expertise and technology to drive smarter healthcare operations.

About RxGPT

RxGPT is an AI-first healthcare intelligence and automation platform focused on transforming how healthcare organizations leverage AI, data, and automation to improve operational efficiency, decision-making, and patient outcomes.

We are building at the intersection of:

• Healthcare AI

• Enterprise SaaS

• Workflow automation

• Data intelligence

• AI-assisted healthcare operations

Our mission is to create a scalable AI healthcare ecosystem capable of serving global markets including the US, UK, GCC, India, and emerging economies.

Why This Role Exists

We are entering the next phase of growth and are looking for experienced operators, investors, founders, healthcare leaders, and strategic advisors who can help RxGPT scale faster.

This is designed for individuals who bring:

• Strategic value

• Capital access

• Industry relationships

• GTM and scaling expertise

• Board-level thinking

This is not a day-to-day execution role.

This is a high-leverage strategic position.

What You Will Do

• Provide strategic guidance on:

• Fundraising

• GTM strategy

• AI healthcare positioning

• Enterprise sales motion

• Product scaling

• Open doors to:

• Follow-on investors

• Healthcare institutions

• Strategic partners

• Enterprise customers

• Advise on:

• Pricing strategy

• Market expansion

• Category positioning

• Enterprise healthcare adoption

• Make targeted introductions to:

• Operators

• Investors

• Healthcare executives

• Potential clients and partners

• Participate in:

• Strategic review calls

• Board/advisory discussions

• Growth planning sessions

• Mentor founders and leadership team on:

• Scaling decisions

• Prioritization

• Long-term strategy

Who This Is For

You are a strong fit if you are one or more of the following:

• Founder or former founder of a successful:

• AI company

• SaaS company

• Healthtech company

• Current or former:

• VP

• C-level executive

• Revenue leader

• Healthcare operator

• Experienced advisor to early-stage technology companies

• Strategic operator with strong network across:

• Healthcare

• AI

• SaaS

• Venture capital

• Enterprise technology

• Angel investor or strategic investor interested in healthcare AI

Why Join RxGPT

• Join early in a company operating in one of the largest emerging AI sectors globally

• Help shape a scalable healthcare AI ecosystem

• Direct access to founding team and strategic decision-making

• Participate in category creation within healthcare AI

• Opportunity for equity ownership and strategic influence

• Build long-term value alongside company growth

Compensation & Investment Structure

Advisory Compensation

• Equity-based advisory compensation

Investment Opportunity

Board advisors and strategic partners may also participate as investors.

Potential structures include:

• Angel investment participation

• Equity allocation

• Strategic investment opportunities

• Board-level equity participation

Expected Involvement

• Estimated involvement:

• 2–4 hours per month

• Flexible engagement model

• No operational day-to-day management required

Additional Qualification Questions

1. Have you helped scale a healthcare, healthtech, AI, or enterprise SaaS company beyond early traction?

2. Are you open to participating in strategic advisory or board discussions for 2–4 hours per month?

3. Would you consider making a strategic investment in RxGPT in exchange for equity participation?